
Research & Clinical Trials – Page 4
-
newsResearch & Clinical TrialsA research team at the National Cancer Institute is developing a novel therapy that could change the treatment paradigm for pleural mesothelioma.
-
newsResearch & Clinical Trials
NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
The National Cancer Institute has opened a promising clinical trial aimed at increasing the effectiveness of immunotherapy treatment for patients with unresectable malignant… -
newsResearch & Clinical Trials
Clinical Trials Lead to Promising Updates in Mesothelioma Immunotherapy
Researchers have made significant progress in mesothelioma treatment advancements recently, including promising work with immunotherapy. The first U.S. Food and Drug Administration-approved combination… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial to Involve Drug Studied for COVID-19
A novel phase II clinical trial for malignant mesothelioma is expected to open soon and involve a versatile, biological drug already showing promise… -
newsResearch & Clinical Trials
University of Vermont Study Opens New Door for Mesothelioma Treatment
Researchers at the University of Vermont Cancer Center have uncovered a new approach to the treatment of malignant pleural mesothelioma, sparking a… -
newsResearch & Clinical Trials
Study Supports Opdivo as Second-Line Mesothelioma Treatment
When the effectiveness of first-line chemotherapy fails and malignant mesothelioma returns, more patients could soon turn with confidence to a proven, second-line… -
newsResearch & Clinical Trials
Researchers Open Phase I Clinical Trial of Cryoablation with Keytruda
Memorial Sloan Kettering Cancer Center in New York City has opened a novel clinical trial that combines the immunotherapy drug Keytruda with… -
newsResearch & Clinical Trials
New Opdivo/Yervoy Mesothelioma Clinical Trial Begins Soon
A novel clinical trial involving the immunotherapy combination of Opdivo and Yervoy will open soon in Chicago. The goal is to study the… -
newsResearch & Clinical Trials
Study Shows Access to Care Often Difficult for Mesothelioma Patients
When it comes to malignant pleural mesothelioma, not everyone is treated equally. A disparity in access to care makes the difference in… -
newsResearch & Clinical Trials
Mesothelioma Research, COVID Findings Featured at IASLC Conference
Researchers from around the world presented their insights into serious lung health issues, including mesothelioma, during the International Association for the Study of…